{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:58:43Z","timestamp":1761919123902,"version":"3.35.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1992,2,1]],"date-time":"1992-02-01T00:00:00Z","timestamp":696902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1992,2,1]],"date-time":"1992-02-01T00:00:00Z","timestamp":696902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1992,2]]},"DOI":"10.1136\/ard.51.2.168","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"168-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis."],"prefix":"10.1016","volume":"51","author":[{"given":"C.Y","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.H","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.H","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.M","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.L","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","first-page":"163","article-title":"Monoclonal antibody analysis of glomerular hypercellularity in human glomerulonephritis","volume":"22","author":"H, Hooke D.; W, Hancock W.; C, Gee D.; N, Kraft; C, Atkins R.","year":"1984","unstructured":"Hooke D H, Hancock W W, Gee D C, Kraft N, Atkins R C. Monoclonal antibody analysis of glomerular hypercellularity in human glomerulonephritis. Clin Nephrol 1984; 22: 163-8.","journal-title":"Clin Nephrol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1987.123","article-title":"Intraglomerular T cells and monocytes in nephritis: study with monoclonal antibodies","volume":"31","author":"B, Nolasco F.E.; S, Cameron J.; B, Hartley; A, Coelho; G, Hildreth; R, Reuben","year":"1987","unstructured":"Nolasco F E B, Cameron J S, Hartley B, Coelho A, Hildreth G, Reuben R. Intraglomerular T cells and monocytes in nephritis: study with monoclonal antibodies. Kidney Int 1987; 31: 1160-6.","journal-title":"Kidney Int"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4049\/jimmunol.130.4.1796","article-title":"A thymocyte-activating factor derived from glomerular mesangial cells","volume":"130","author":"H, Lovett D.; L, Ryan J.; B, Sterzel R.","year":"1983","unstructured":"Lovett D H, Ryan J L, Sterzel R B. A thymocyte-activating factor derived from glomerular mesangial cells. J Immunol 1983; 130: 1796-801.","journal-title":"J Immunol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4049\/jimmunol.141.1.118","article-title":"Novel and enhanced IL-1 gene expression in autoimmune mice with lupus","volume":"141","author":"M, Boswell J.; A, Yui M.; S, Endres; W, Burt D.; E, Kelley V.","year":"1988","unstructured":"Boswell J M, Yui M A, Endres S, Burt D W, Kelley V E. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J Immunol 1988; 141: 118-24.","journal-title":"J Immunol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.4049\/jimmunol.141.9.3050","article-title":"Increased tumor necrosis factor and IL-lI') gene expression in the kidneys of mice with lupus nephritis","volume":"141","author":"M, Boswell J.; A, Yui M.; W, Burt D.; E, Kelley V.","year":"1988","unstructured":"Boswell J M, Yui M A, Burt D W, Kelley V E. Increased tumor necrosis factor and IL-lI') gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988; 141: 3050-4.","journal-title":"J Immunol"},{"key":"ref_6","first-page":"281","article-title":"Mononuclear cells in glomeruli and cytokines in urine reflect the severity of experimental proliferative immune complex glomerulonephritis. Clin Exp Immunol","volume":"80","author":"Noble, B.; Ren, K.; Taverne, J.","year":"1990","unstructured":"Noble B, Ren K, Taverne J, et al. Mononuclear cells in glomeruli and cytokines in urine reflect the severity of experimental proliferative immune complex glomerulonephritis. Clin Exp Immunol 1990; 80: 281-7."},{"key":"ref_7","first-page":"122","article-title":"Evidence by radioimmunoassay that mitogen-activated human blood mononuclear cells secrete significant amounts of light chain Ig unassociated with heavy chain","author":"HopperJ, E.; Papagiannes, E.","unstructured":"HopperJ E, Papagiannes E. Evidence by radioimmunoassay that mitogen-activated human blood mononuclear cells secrete significant amounts of light chain Ig unassociated with heavy chain. Cell Immunol 1986.; 101: 122-31."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9343(73)90121-6","article-title":"Immunologic events preceding clinical exacerbation of systemiclupus erythematosus","volume":"54","author":"V, Epstein W.","year":"1973","unstructured":"Epstein W V. Immunologic events preceding clinical exacerbation of systemiclupus erythematosus. Am J Med 1973;54: 631-6.","journal-title":"Am J Med"},{"key":"ref_9","first-page":"1541","article-title":"A urine iI(nthiabnidt1otrI of interleukin 1 but not tumor activity affects necrosis factor(t","volume":"139","author":"Seckinger, P.; Williamson, K.; Balavoine, J.-F.","year":"1987","unstructured":"Seckinger P, Williamson K, Balavoine J-F, et al. A urine iI(nthiabnidt1otrI of interleukin 1 but not tumor activity affects necrosis factor(t. both interleukin J Immunol 1987; 139: 1541-5.","journal-title":"both interleukin J Immunol"},{"key":"ref_10","first-page":"1511","article-title":"A human inhibitor of tumor necrosis factora. j Exp Med","volume":"167","author":"Seckinger, P.; IsaazS, Dayer; J.-M.","year":"1988","unstructured":"Seckinger P, IsaazS, Dayer J-M. A human inhibitor of tumor necrosis factora. j Exp Med 1988; 167:1511-6."},{"key":"ref_11","first-page":"3207","article-title":"The inter-leukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis","volume":"138","author":"Werber, H.I.; N, Emancipator S.; L, Tykocinski M.; R, Sedor J.","year":"1987","unstructured":"Werber HI, Emancipator S N, Tykocinski M L, Sedor J R. The inter-leukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. 7 Immunol 1987; 138: 3207-12."},{"key":"ref_12","first-page":"314","article-title":"Heyden A A PAM, Aarden LA. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol","volume":"71","author":"J, Van Oers M.H.; Der, Van","year":"1988","unstructured":"Van Oers M H J, Van Der Heyden A A PAM, Aarden LA. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.Clin Exp Immunol 1988; 71: 314-9."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI114731","article-title":"Elevated expression of transforming growth factor-ji and proteoglycan production in experimental glomerulonephritis: possible role in expansion of mesangial extracellular matrix","volume":"86","author":"OkudaS, Languino L.R.; E, Ruoslahti; A, Border W.","year":"1990","unstructured":"OkudaS, Languino L R, Ruoslahti E, Border W A. Elevated expression of transforming growth factor-ji and proteoglycan production in experimental glomerulonephritis: possible role in expansion of mesangial extracellular matrix. Clin Invest 1990; 86:453-62.","journal-title":"Clin Invest"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro","volume":"135","author":"A, Rubin L.; C, Kurman C.; E, Fritz M.","year":"1985","unstructured":"Rubin L A, Kurman C C, Fritz M E, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172-7.","journal-title":"J Immunol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780310605","article-title":"Soluble interleukin-2 receptors in systemic lupus erythematosus","volume":"31","author":"E, Wolf R.; G, Brelsford W.","year":"1988","unstructured":"Wolf R E, Brelsford W G. Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 1988; 31: 729-35.","journal-title":"Arthritis Rheum"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/ard.48.10.803","article-title":"Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus","volume":"48","author":"Tokano, Y.; Murashima, A.; Takasaki, Y.; Hashimoto, H.; Okumura, K.; Hirose, S.","year":"1989","unstructured":"Tokano Y, Murashima A, Takasaki Y, Hashimoto H, Okumura K, Hirose S. Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 803-9.","journal-title":"Ann Rheum Dis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.170.4.1409","article-title":"Soluble cytokine receptors are present in normal human urine","volume":"170","author":"Novick, D.; Engelmann, H.; Wallach, D.; Rubinstein, M.","year":"1989","unstructured":"Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. JExpMed 1989; 170: 1409-14.","journal-title":"JExpMed"},{"key":"ref_18","first-page":"273","article-title":"Immune-mediated mesangial cell injury-biosynthesis and function of prostanoids","volume":"38","author":"K, Stahl R.A.; F, Thaiss; S, Kahf; W, Schoeppe; M, Helmchen U.","year":"1990","unstructured":"Stahl R A K, Thaiss F, Kahf S, Schoeppe W, Helmchen U M. Immune-mediated mesangial cell injury-biosynthesis and function of prostanoids. KidneIy nt 1990; 38:273-81.","journal-title":"KidneIy nt"},{"key":"ref_19","first-page":"2162","article-title":"The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia","volume":"51","author":"A, Waldmann T.; W, Strober; P, Mogielnicki R.","year":"1972","unstructured":"Waldmann T A, Strober W, Mogielnicki R P. The renal handling of low molecular weight proteins.II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. JClin Invest 1972; 51: 2162-74.","journal-title":"JClin Invest"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724103160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724103160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.51.2.168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:16:40Z","timestamp":1738304200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724103160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,2]]}},"alternative-id":["S0003496724103160"],"URL":"https:\/\/doi.org\/10.1136\/ard.51.2.168","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1992,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.51.2.168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1992 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}